Full-Time

Buyer II

Deadline 11/16/26
Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

Compensation Overview

$60k - $75.4k/yr

Albany, NY, USA

In Person

On-site at Rensselaer, New York.

Bachelor's, Associate's

Category
Operations & Logistics (1)

Get referred to Curia

See people who can refer or advise you

Requirements
  • Associates degree, preferably in procurement or supply chain
  • Minimum 3-5 years’ relevant experience
  • Ability to work under pressure and to tight deadlines
  • Ability to make sound independent judgments regularly
  • Effective time management, organization and prioritization skills
  • Highly persuasive
  • Process driven approach to problem solving
  • Strong analytical and problem-solving skills with high attention to detail and accuracy
  • Strong interpersonal skills with a proven ability to form close, amicable, trusting relationships across businesses, internal functions, and across all levels within an enterprise
  • Strong verbal English and written English communication skills
Responsibilities
  • Enter data of purchase orders for sites that they support into accounting system, which includes assignment of general ledger codes, project, task and sub account codes on all items ordered on a daily basis
  • Interface with new vendors to obtain proper paperwork for new supplier creation, including completion of the New Supplier Information Form and necessary local tax forms
  • Work with Accounts Payable for sites that they support to research discrepancies on invoices and call vendors to resolve and /or obtain credit
  • Interact with end users for the sites that they support and vendors to track orders to get expected delivery dates
  • Expedite and de-expedite Purchase Orders
  • Review the “Past Due Purchase Order” report and collaborate with the end user and vendors to resolve and close as necessary
  • Process of purchasing requisitions in a timely manner on a daily basis
  • Work in shifts, depending upon job requirement
  • Collaborate with Category Managers / Local Procurement Team to implement and enforce the terms and conditions of any applicable global or regional strategic agreements at the local level
  • Verify specifications of purchase requests as needed
  • Ensure continuous improvement through the collection and tracking of relevant cost, quality, and service data
  • Recommend and implement methods to improve Purchase Order conversion time and lead time
  • Participate in self-development activities and training of others
  • Understand and enforce Procurement procedures and processes to ensure that all purchases are approved sufficiently and in-compliances with Curia’s policies
  • Exhibit safety awareness and safe work practices
  • Communicate proactively and effectively with all relevant functions and personnel
  • Conduct business with the highest level of integrity ensuring compliance with the Curia Code of Ethics and Business Conduct
  • Maintain the highest levels of professionalism both at the Curia sites and with suppliers at their sites
Desired Qualifications
  • Bachelor’s degree, preferably in procurement or supply chain
  • Knowledge of Pharmaceutical or Life Sciences industry a plus

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Albuquerque’s $200 million expansion adds commercial drug-product capacity during 2025-2026.
  • Glasgow’s upgrade reaches early 2027, expanding batches to 20,000 vials.
  • March 2025 refinancing and July 2026 recapitalization inject capital for near-term execution.

What critics are saying

  • Apollo-led recapitalization on July 8, 2026 signals strained leverage and lender control.
  • Curia will close Burlington by June 1, 2026, cutting 81 jobs and shrinking capacity.
  • Octus reported June 2, 2026 out-of-court restructuring talks; a failed process risks insolvency.

What makes Curia unique

  • Curia spans discovery through commercial fill-finish across 20+ sites, rare among CDMOs.
  • Glasgow and Albuquerque expansions deepen sterile injectables capacity, including Annex 1 isolator lines.
  • Hopkinton CLD upgrades deliver sixfold higher titers, strengthening biologics process-development economics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.